Grant: Operating Grant: Joint Programme on Neurodegenerative Disease Research (JPND)
McGill University
$333,000.00
BRain Imaging, cognition, Dementia and next generation GEnomics: a Transdisciplinary approach to search for risk and protective factors of neurodegenerative disease
EF 2015-16
Résumé
Establishing efficient prevention strategies for dementia and Alzheimer disease (AD) is a major health priority for the coming years. An important hurdle is that pathological processes leading to AD begin many years before clinical diagnosis, hence efficient prevention should be initiated very early. This requires identifying individuals in the general population who are at high risk of developing dementia and exploring the molecular pathways underlying the structural brain alterations that precede the occurrence of dementia, an essential step for identifying novel relevant drug targets. We propose to explore the genetic and epigenetic determinants of quantitative MRI-markers of brain aging that are powerful predictors of dementia/AD risk, and to examine the clinical significance of the markers in a population-based setting. Leveraging the extensive information collected within the largest European population-based cohort studies with neuroimaging data, we will first search for genetic variants associated with established and novel MRI-markers of brain aging, focusing particularly on rare variants. Second, we will take an original lifetime perspective, through examination of samples in various age categories, many with repeated MRI and blood sampling. We propose an innovative exploration of lifetime changes in methylation associated with structural brain alterations to help identify functional and disease relevant variants. We will also study the modifying effects of vascular risk factors and socio-economic status on genetic/epigenetic determinants of brain aging. Third, we will explore the clinical and functional significance of the genetic and epigenetic markers and examine their association with cognitive performance & decline and risk of dementia/AD.
Programme
Operating Grant: Joint Programme on Neurodegenerative Disease Research (JPND)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
332921
Name
Pastinen Tomi
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Deutsches Zentrum fur Luft- und Raumfahrt (Germany); Federal Ministry of Science, Research and Economy (Austria); Medical Research Council (UK); National Health and Medical Research Council of Australia; The French National Research Agency (France); The Netherlands Organization for Health Research and Development (ZonMw)
Instname2
Genetics
Theme2
Biomedical
Prcname2
Special Cases
Projecttitle
BRain Imaging, cognition, Dementia and next generation GEnomics: a Transdisciplinary approach to search for risk and protective factors of neurodegenerative disease
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$333,000
Cihrequipment2
$0
Programname2
Operating Grant: Joint Programme on Neurodegenerative Disease Research (JPND)
Keyworddelim
Alzheimer Disease; Cognition; Methylation; Mri-Markers Of Brain Aging; Next Generation Sequencing; Population-Based Longitudinal Cohort
Abstract
Establishing efficient prevention strategies for dementia and Alzheimer disease (AD) is a major health priority for the coming years. An important hurdle is that pathological processes leading to AD begin many years before clinical diagnosis, hence efficient prevention should be initiated very early. This requires identifying individuals in the general population who are at high risk of developing dementia and exploring the molecular pathways underlying the structural brain alterations that precede the occurrence of dementia, an essential step for identifying novel relevant drug targets. We propose to explore the genetic and epigenetic determinants of quantitative MRI-markers of brain aging that are powerful predictors of dementia/AD risk, and to examine the clinical significance of the markers in a population-based setting. Leveraging the extensive information collected within the largest European population-based cohort studies with neuroimaging data, we will first search for genetic variants associated with established and novel MRI-markers of brain aging, focusing particularly on rare variants. Second, we will take an original lifetime perspective, through examination of samples in various age categories, many with repeated MRI and blood sampling. We propose an innovative exploration of lifetime changes in methylation associated with structural brain alterations to help identify functional and disease relevant variants. We will also study the modifying effects of vascular risk factors and socio-economic status on genetic/epigenetic determinants of brain aging. Third, we will explore the clinical and functional significance of the genetic and epigenetic markers and examine their association with cognitive performance & decline and risk of dementia/AD.
Competitiondate
201506
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Pastinen, Tomi
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $333,000~ $0~